XTENT Inc (XTNT)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Carl D. O'Connell
Employees:
166
664 CRUISER LANE, BELGRADE, MT 59714
406-388-0480

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Xtant Medical Holdings, Inc. operates as a holding company, which supplies orthopedic and spine surgery products. The company operates through its subsidiaries, Bacterin International, Inc. and X-spine Systems, Inc. Bacterin International develops, manufactures, and markets biologics products to domestic and international markets. Its products are bone graft, which are used in promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries; and custom surgical products used for allografts. X-spine Systems is a manufacturer of implants and instruments for surgery of the spine and sacroiliac joint. Its products are used for the treatment of degenerative spine disorders. The company is headquartered in Belgrade, MT.

Data derived from most recent annual or quarterly report
Market Cap 14.435 Million Shares Outstanding23.283 Million Avg 30-day Volume 58.431 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

Are you looking for these stocks instead?

View SEC Filings from XTNT instead.

View recent insider trading info

Funds Holding XTNT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding XTNT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARCO PHILIPPE H VP-QA, CLINICAL & REG. AFFAIRS

  • Officer
69,800 2008-10-01 0

CASCIARO GREGORY D PRESIDENT AND CEO

  • Officer
  • Director
0 2008-08-13 0

ANDREAS BERNARD H VP-INNOVATION AND CONCEPT DEV

  • Officer
No longer subject to file 2008-08-13 0

CAMPBELL RANDOLPH E CHIEF TECHNICAL OFFICER

  • Officer
0 2008-08-13 0

KAHLENBERG TIMOTHY D CHIEF FINANCIAL OFFICER

  • Officer
0 2008-08-13 0

HODKINSON ANNE-MARIE VP HUMAN RESOURCES

  • Officer
0 2008-08-13 0

WALSH BRIAN J

  • FORMER VP-SALES & MARKETING
No longer subject to file 2008-07-18 0

TAYLOR ARTHUR T

  • Director
0 2008-06-18 0

FLAHERTY ROBERT E

  • Director
0 2008-06-18 0

SPLIT ROCK PARTNERS LLC

SPVC VI, LLC

  • 10% Owner
2,615,135 2008-06-18 0

EAGLE MICHAEL L

  • Director
0 2008-06-18 0

UNKART EDWARD W

  • Director
0 2008-06-18 0

CARUSI MICHAEL A

  • Director
0 2008-06-18 0

WILL ALLAN R

  • Director
  • 10% Owner
2,775,291 2008-06-18 0

PLAIN HENRY A JR

  • Director
0 2008-06-18 0

SMITH CHRISTOPHER M

  • Director
0 2008-06-18 0

GRAINGER JEFFRY J VP-CORP AFFAIRS & GEN. COUNSEL

  • Officer
109,500 2008-04-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments